
Cognyte Software Ltd. CGNT
$ 8.8
0.85%
Annual report 2025
added 03-21-2026
Cognyte Software Ltd. Total Liabilities 2011-2026 | CGNT
Annual Total Liabilities Cognyte Software Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 281 M | 257 M | 233 M | 366 M | 358 M | 350 M | - | - | 10.7 M | 10.1 M | 34 M | 25.3 M | 20 M | 13 M | 13.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 366 M | 10.1 M | 152 M |
Quarterly Total Liabilities Cognyte Software Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 366 M | - | - | - | 358 M | - | - | - | 350 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 366 M | 350 M | 358 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.58 | -0.11 % | $ 122 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.0 | -0.58 % | $ 1.62 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Globus Medical
GMED
|
730 M | $ 90.43 | 2.07 % | $ 12.2 B | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.11 | -2.88 % | $ 258 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 36.38 | -0.98 % | $ 5.42 K | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.8 | -5.53 % | $ 1.09 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.25 | -0.64 % | $ 712 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 54.48 | 0.63 % | $ 1.6 B | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | 3.35 % | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.52 | -0.13 % | $ 2.97 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.77 | -2.04 % | $ 69 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.82 | -0.75 % | $ 371 M | ||
|
Medtronic PLC
MDT
|
43.4 B | $ 86.33 | 0.06 % | $ 111 B | ||
|
EDAP TMS S.A.
EDAP
|
34.6 M | $ 3.42 | -1.16 % | $ 128 M | ||
|
Myomo
MYO
|
27.2 M | $ 0.67 | -4.85 % | $ 28 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
2.36 B | $ 168.21 | -2.13 % | $ 12.6 B | ||
|
Orthofix Medical
OFIX
|
401 M | $ 11.81 | 0.34 % | $ 468 M | ||
|
AxoGen
AXGN
|
92.8 M | $ 31.01 | -4.99 % | $ 1.43 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 204.23 | 0.36 % | $ 14.4 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.76 | 9.09 % | $ 7.65 M | ||
|
Smith & Nephew plc
SNN
|
5.17 B | $ 31.76 | -2.67 % | $ 23.8 B | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.02 | -2.66 % | $ 851 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 331.18 | -0.34 % | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
55 M | $ 24.16 | -1.67 % | $ 553 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
TELA Bio
TELA
|
75.1 M | $ 0.7 | 11.11 % | $ 32.9 M | ||
|
TransMedics Group
TMDX
|
595 M | $ 107.91 | 2.97 % | $ 3.67 B | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 18.66 | -2.66 % | $ 1.27 B | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 9.68 | -0.21 % | $ 347 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 61.33 | -2.01 % | $ 90.8 B | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 11.09 | 1.05 % | $ 1.66 B |